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It is well known that after the initial months of implantable
cardioverter-deﬁbrillator (ICD) implantation, there is a peak
in the incidence of appropriate ICD therapies because of the
local irritation effect of the lead on myocardial tissue.
Moreover, there is growing evidence of the proarrhythmic
effects of pacemaker or ICD leads long after implantation.
The pathophysiologic mechanism can be lead fracture,
epicardial perforation, local scar formation around the tip,
or a change in the activation pattern of the ventricles caused
by epicardial or endocardial pacing.1–4 Proof of lead-related
arrhythmogenesis is based on indirect evidence such as
identical pace-map from the lead tip, activation or voltage
mapping, or noninducibility of the tachycardia after lead
removal.2 The aim of this report is to present the ﬁrst direct
human pathologic evidence of a probable ICD lead-related
scar causing ventricular tachycardia (VT).
Case report
A 50-year-old man with a history of myocardial infarction in
1991 and coronary artery bypass graft surgery 1 year later
underwent dual-chamber ICD implantation for secondary
prevention in 2003. He was suffering from chronic heart
failure of ischemic origin and recurrent VTs, so VT ablation
was performed at another institution in 2008. The ICD
system was removed completely because of a generatorKEYWORDS Implantable cardioverter-deﬁbrillator lead proarrhythmia;
Ventricular tachycardia substrate; Pathology specimen
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chamber ICD system was implanted from the opposite side.
In the 2 years after reimplantation, he presented with
multiple, appropriate, effective ICD therapies because of
sustained monomorphic VTs with at least 5 different
morphologies having different cycle lengths (300, 480,
420, 540, and 560 ms). Left ventricular ejection fraction
was 26%. Coronary angiography revealed occluded
native coronaries and intact bypass grafts. The patient was
placed on the waiting list for orthotopic heart transplantation
in 2009. Because the VTs were drug resistant despite
administration of amiodarone and mexiletine and were
causing multiple ICD discharges, radiofrequency catheter
ablation (RFCA) was performed at our institution in 2010.
Multiple inducible VT morphologies were observed during
the study, and electroanatomic mapping identiﬁed an exten-
sive low-voltage area corresponding to the anteroseptal–
apical scar tissue of the remote myocardial infraction. After
isolated late potentials and exit points were successfully
targeted by RFCA, only 1 sustained VT morphology
remained.
The ultimate VT morphology closely resembled the paced
QRS morphology. It also was clinically relevant according to
a previous ECG of a spontaneous VT episode with a cycle
length of 560 ms (Figure 1). Further pace-mapping located
this VT close to the screw-in tip of the steroid-eluting
deﬁbrillator lead (Guidant Endotak Reliance G 0185, Boston
Scientiﬁc, St. Paul, MN) in the apical aspect of the
interventricular septum. The area around the lead tip was
then approached from both the left and right sides of the
interventricular septum. A magnetic navigation enabled
catheter was used in the left ventricle,5 but the ablation
attempts were not successful (Figure 2). A new ventricular
pace/sense electrode was implanted at the end of the
procedure because of sensing failure of the shock lead after
ablation. Three weeks after ablation, the patient underwent
orthotopic heart transplantation. This provided us the unique
opportunity to investigate the explanted heart with the
electrode tip in situ and to directly visualize the tip-related
scar (Figure 3), which corresponded to the site of originpen access article under the CC BY-NC-ND license
http://dx.doi.org/10.1016/j.hrcr.2014.10.001
KEY TEACHING POINTS
 Implanted ICDs can have a clinically relevant
proarrhythmic effect, which can manifest long after
device implantation. Although rare, scar formation
around the lead tip can serve as a substrate for
ventricular tachycardia.
 Comparing the ECG of the clinical ventricular
tachycardia to the paced QRS morphology can be
the clue to correct diagnosis. Pace-mapping can
help localize the source of origin.
 Pathologic examination of the explanted heart
directly clariﬁed the substrate of this particular
ventricular arrhythmia. Even use of a steroid-
eluting lead could not prevent signiﬁcant scar
formation around the tip.
11Abraham et al Direct Evidence of Lead-Related Proarrhythmiapreviously identiﬁed by pace-mapping. As clearly demon-
strated by the pathology specimen, the location of the scar
was unreachable by any ablation catheter, thus explainingFigure 1 Twelve-lead ECGs with paced QRS complexes and during a spontaneo
ms. Note that the ventricular pacing morphology, albeit not fully identical, is cl
morphologies is explained by the anatomic location of the scar (see Figure 3 for dwhy RFCAwas unsuccessful in this area. Moreover, this scar
was well separated from the infarct-related scar, which was
unrelated to the ultimate tachycardia (Figure 3).Discussion
To the best of our knowledge, this likely tip-related scar is
the ﬁrst direct human pathologic evidence of lead-related
arrhythmogenesis, which was identiﬁed as a substrate of a
clinically relevant VT. One can speculate that the lead tip
probably caused local damage to a tributary coronary branch
with consequent hemorrhage and scar formation around the
tip, and this could be the pathophysiologic mechanism.
Unfortunately, we do not have straightforward imaging
evidence that this scar did not exist previously and that the
scar developed only after ICD lead implantation, but we
believe that our data are quite compelling. In the setting of
unexplained VTs or VT storm, this possible lead complica-
tion deserves more attention. Given the possible mechanism,
even a steroid-eluting lead design cannot prevent signiﬁcant
scar formation around the tip.4us sustained ventricular tachycardia (VT) episode with a cycle length of 560
osely related to the morphology of the VT. The slight difference in QRS
etails).
Figure 2 Fluoroscopic images in the left anterior oblique (LAO) and right anterior oblique (RAO) projections depicting the mapping/ablation catheter (M)
placed in the right ventricle via transjugular access. The site of origin of the ventricular tachycardia is in close proximity to the tip of the shock lead (L). RV ¼
diagnostic catheter in the right ventricle.
Figure 3 Top: Oblique cross-sectional macroscopic pathology specimen of
the explanted heart at the apical level of the right ventricle (white dotted circle) de-
monstrating scar tissue (black dotted circle) around the tip of the explanted
implantable cardioverter-deﬁbrillator lead and the 3-week-old necrotic, hemor-
rhagic lesions of 2 radiofrequency applications (arrows). One lesion was created
from the left ventricle and the other from the right ventricle. The location of the scar
explains why a fully identical pace-map could not be achieved, because this region
was unreachable by any of the catheters. Note that the extensive scar of the old
myocardial infarction is separated from this scar. Bottom: Another aspect of the
explanted heart showing the distinct scar caused by the tip and the extensive infarc-
tion scar tissue. Orientation: A¼ anterior; L¼ lateral; P ¼ posterior; S ¼ septal.
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